Cargando…
An Analysis of the Social and Economic Costs of Breast Cancer in Italy
Background: Breast cancer is the most prevalent cancer affecting women and it represents an important economic burden. The aim of this study was to estimate the socio-economic burden of breast cancer (BC) in Italy both from the National Health Service (NHS) and the government perspectives (costs bor...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431604/ https://www.ncbi.nlm.nih.gov/pubmed/34501588 http://dx.doi.org/10.3390/ijerph18179005 |
_version_ | 1783750976655589376 |
---|---|
author | Mennini, Francesco Saverio Trabucco Aurilio, Marco Gazzillo, Simone Nardone, Claudia Sciattella, Paolo Marcellusi, Andrea Migliorini, Raffaele Sciannamea, Valerio Piccioni, Andrea Bolcato, Matteo Barni, Sandro |
author_facet | Mennini, Francesco Saverio Trabucco Aurilio, Marco Gazzillo, Simone Nardone, Claudia Sciattella, Paolo Marcellusi, Andrea Migliorini, Raffaele Sciannamea, Valerio Piccioni, Andrea Bolcato, Matteo Barni, Sandro |
author_sort | Mennini, Francesco Saverio |
collection | PubMed |
description | Background: Breast cancer is the most prevalent cancer affecting women and it represents an important economic burden. The aim of this study was to estimate the socio-economic burden of breast cancer (BC) in Italy both from the National Health Service (NHS) and the government perspectives (costs borne by the social security system). Methods: The economic analysis was based on the costs incurred by the NHS from 2008 to 2016 (direct costs related to hospitalizations) and by the National Social Security Institute (INPS) from 2009 to 2015 (costs of social security benefits) for patients with breast cancer. The analysis was based on the Hospital Information System (HIS) and Disability Insurance Awards databases. For both databases, patients affected by a malignant neoplasm of the female breast, carcinoma in situ, or secondary malignant neoplasm of the breast were considered. Results: Results show that more than 75,000 women were hospitalized for breast cancer every year, with an overall cost for hospitalization of about €300 million per year. From the Social Security analysis, a number of 29,000 beneficiaries each year was estimated. Considering per patient social costs, breast cancer at the primary stage cost €8828 per year, while secondary neoplasms cost €9780, with an average total economic burden of €257 million per year. Conclusions: This analysis focused on the economic impact of breast cancer in Italy, showing that an advanced stage of the disease was associated with a higher cost. |
format | Online Article Text |
id | pubmed-8431604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84316042021-09-11 An Analysis of the Social and Economic Costs of Breast Cancer in Italy Mennini, Francesco Saverio Trabucco Aurilio, Marco Gazzillo, Simone Nardone, Claudia Sciattella, Paolo Marcellusi, Andrea Migliorini, Raffaele Sciannamea, Valerio Piccioni, Andrea Bolcato, Matteo Barni, Sandro Int J Environ Res Public Health Article Background: Breast cancer is the most prevalent cancer affecting women and it represents an important economic burden. The aim of this study was to estimate the socio-economic burden of breast cancer (BC) in Italy both from the National Health Service (NHS) and the government perspectives (costs borne by the social security system). Methods: The economic analysis was based on the costs incurred by the NHS from 2008 to 2016 (direct costs related to hospitalizations) and by the National Social Security Institute (INPS) from 2009 to 2015 (costs of social security benefits) for patients with breast cancer. The analysis was based on the Hospital Information System (HIS) and Disability Insurance Awards databases. For both databases, patients affected by a malignant neoplasm of the female breast, carcinoma in situ, or secondary malignant neoplasm of the breast were considered. Results: Results show that more than 75,000 women were hospitalized for breast cancer every year, with an overall cost for hospitalization of about €300 million per year. From the Social Security analysis, a number of 29,000 beneficiaries each year was estimated. Considering per patient social costs, breast cancer at the primary stage cost €8828 per year, while secondary neoplasms cost €9780, with an average total economic burden of €257 million per year. Conclusions: This analysis focused on the economic impact of breast cancer in Italy, showing that an advanced stage of the disease was associated with a higher cost. MDPI 2021-08-26 /pmc/articles/PMC8431604/ /pubmed/34501588 http://dx.doi.org/10.3390/ijerph18179005 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mennini, Francesco Saverio Trabucco Aurilio, Marco Gazzillo, Simone Nardone, Claudia Sciattella, Paolo Marcellusi, Andrea Migliorini, Raffaele Sciannamea, Valerio Piccioni, Andrea Bolcato, Matteo Barni, Sandro An Analysis of the Social and Economic Costs of Breast Cancer in Italy |
title | An Analysis of the Social and Economic Costs of Breast Cancer in Italy |
title_full | An Analysis of the Social and Economic Costs of Breast Cancer in Italy |
title_fullStr | An Analysis of the Social and Economic Costs of Breast Cancer in Italy |
title_full_unstemmed | An Analysis of the Social and Economic Costs of Breast Cancer in Italy |
title_short | An Analysis of the Social and Economic Costs of Breast Cancer in Italy |
title_sort | analysis of the social and economic costs of breast cancer in italy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431604/ https://www.ncbi.nlm.nih.gov/pubmed/34501588 http://dx.doi.org/10.3390/ijerph18179005 |
work_keys_str_mv | AT menninifrancescosaverio ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT trabuccoauriliomarco ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT gazzillosimone ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT nardoneclaudia ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT sciattellapaolo ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT marcellusiandrea ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT miglioriniraffaele ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT sciannameavalerio ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT piccioniandrea ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT bolcatomatteo ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT barnisandro ananalysisofthesocialandeconomiccostsofbreastcancerinitaly AT menninifrancescosaverio analysisofthesocialandeconomiccostsofbreastcancerinitaly AT trabuccoauriliomarco analysisofthesocialandeconomiccostsofbreastcancerinitaly AT gazzillosimone analysisofthesocialandeconomiccostsofbreastcancerinitaly AT nardoneclaudia analysisofthesocialandeconomiccostsofbreastcancerinitaly AT sciattellapaolo analysisofthesocialandeconomiccostsofbreastcancerinitaly AT marcellusiandrea analysisofthesocialandeconomiccostsofbreastcancerinitaly AT miglioriniraffaele analysisofthesocialandeconomiccostsofbreastcancerinitaly AT sciannameavalerio analysisofthesocialandeconomiccostsofbreastcancerinitaly AT piccioniandrea analysisofthesocialandeconomiccostsofbreastcancerinitaly AT bolcatomatteo analysisofthesocialandeconomiccostsofbreastcancerinitaly AT barnisandro analysisofthesocialandeconomiccostsofbreastcancerinitaly |